About NDE Pharmaceutical
NDE Pharmaceutical is a company based in Solan (India) founded in 2021. NDE Pharmaceutical offers products and services including ND-VIT Capsules and Aclofen Tablets.
- Headquarter Solan, India
- SectorsHealthcare
- Email••••••••
- Legal Name Nde Pharmaceutical Private Limited
- Date of Incorporation 20 Nov, 2018
- Jurisdiction Bhopal, Madhya Pradesh, India
- Annual Revenue₹17.6 Lakh
FY 2025 · -39% YoY
- Net Profit₹30,558
FY 2025 · 2% margin
- EBITDA₹2.8 Lakh
FY 2025 · 16% margin
Associated legal entities of NDE Pharmaceutical
NDE Pharmaceutical operates through Nde Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nde Pharmaceutical Private Limited CIN U85100MP2018PTC047095 | Active | 20 Nov 2018 | Bhopal, Madhya Pradesh | ₹0.2 Cr | – | 2 | View details |
Products & Services of NDE Pharmaceutical
NDE Pharmaceutical offers a comprehensive portfolio of products and services, including ND-VIT Capsules and Aclofen Tablets.
Capsules are supplied for vitamin supplementation and related health needs.
Tablets are offered for the management of pain and inflammation associated with conditions like arthritis.
Board of directors of Nde Pharmaceutical Private Limited (NDE Pharmaceutical)
Nde Pharmaceutical Private Limited is the primary company behind NDE Pharmaceutical. The board of Nde Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Sita Lodhi, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sita Lodhi DIN 08283007 | Director | 20 Nov 2018 | 7 yrs 10 mo | Nde Pharmaceutical Private Limited |
| Pooja Vishwkarma DIN 08283008 | Director | 20 Nov 2018 | 7 yrs 10 mo | Nde Pharmaceutical Private Limited |
Financials of NDE Pharmaceutical
Figures of Nde Pharmaceutical Private Limited, the primary company behind NDE Pharmaceutical, for FY 2025. Revenue was ₹17.6 Lakh (-39% year on year). Net profit was ₹30,558 (2% margin). EBITDA was ₹2.8 Lakh (16% margin). Revenue has grown at a compounded annual rate of 0% over three years and +20% over five years.
- ₹17.6 LakhRevenue · FY 2025 · -39% YoY
- ₹30,558Net profit · 2% margin
- ₹2.8 LakhEBITDA · 16% margin
- ₹2 LakhPaid-up capital
- 0%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nde Pharmaceutical Private Limited are on its company page.
Detailed financial statements for NDE Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to NDE Pharmaceutical
10 companies that operate in the same segment as NDE Pharmaceutical (Pain Management), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 | |
Therapeutics for migraine treatment are developed using nasal delivery. | 2016 | San Francisco, California, United States | USD 74.13 M | – | 24 | |
Pain treatment products are developed through reformulation technologies. | 2007 | Herzliya, Central District, Israel | USD 12 M | USD 17 K | 6 | |
Drug delivery systems for CNS disorders and pain are developed. | 2006 | Emeryville, California, United States | USD 149.06 M | – | – | |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment | 2010 | Bloomington, Indiana, United States | USD 530 M | USD 91.65 M | – | |
Therapies for pain and addiction treatment are developed. | 1977 | Saint-cloud, France | USD 248.09 M | USD 167.87 M | – | |
Novel drug products for chronic pain treatment are developed. | 2007 | Blue Bell, Pennsylvania, United States | USD 12.96 M | – | 17 | |
Abuse-deterrent extended-release therapeutics for chronic pain are developed. | 2002 | Canton, Ohio, United States | USD 103 M | USD 780.57 M | 357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NDE Pharmaceutical
NDE Pharmaceutical was founded in 2021.
NDE Pharmaceutical is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
The primary company behind NDE Pharmaceutical, Nde Pharmaceutical Private Limited, reported revenue of ₹17.6 Lakh for FY 2025, down 39% year on year.
NDE Pharmaceutical is committed to transforming the medical field by supplying high-quality formulations that address various health issues, including sprain, arthritis, and surgical procedures. Affordable and patient-centric medicines are provided through continuous innovation to enhance quality of life for stakeholders. Credibility is earned globally by anticipating patient needs and exceeding expectations, while core values ensure a sustainable organization built on ethical practices. Products such as capsules and syrups are made available for economical treatment.
NDE Pharmaceutical offers ND-VIT Capsules and Aclofen Tablets.
NDE Pharmaceutical operates through Nde Pharmaceutical Private Limited.
The legal entities of NDE Pharmaceutical currently have 2 directors, including Sita Lodhi, Pooja Vishwkarma.